𝔖 Bobbio Scriptorium
✦   LIBER   ✦

U.S. drug and biologic approvals in 1994–1995

✍ Scribed by John F. Beary III; Christina M. Duchaine; Reginald W. Rhein Jr.

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
784 KB
Volume
37
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

✦ Synopsis

Since the introduction of the Prescription D r u g User Fee in 1992, the mean approval time for new drugs has decreased from 29.9 months (1992) t o 19.2 months (1995). In 1994, 22 new drugs and 1 biological were approved. In 1995, 28 drugs and 2 biologicals were approved.

📜 SIMILAR VOLUMES

U.S. drug and biologic approvals in 1996
U.S. drug and biologic approvals in 1996
✍ John F. Beary III; Lara E. Robillard; Gillian R. Woollett; John D. Siegfried; Th 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views

Since the introduction of the Prescription Drug User Fee Act of 1992, the mean approval time for new drugs has decreased from 29.9 months (1992) to 17.8 months (1996).

US drug and biologic approvals in 1998
US drug and biologic approvals in 1998
✍ Bert Spilker; Stacey FitzSimmons; Michael Horan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

The Prescription Drug User Fee Act of 1992 enhanced review resources for the Food and Drug Administration (FDA). The past 3 years have seen an unprecedented approval of 122 new drugs and 28 new biologics. Information is provided on the 39 new products approved by the

US drug and biologic approvals in 1997
US drug and biologic approvals in 1997
✍ John F. Beary III; John D. Siegfried; Renee Tavares 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 837 KB

The Prescription Drug User Fee Act of 1992 enhanced review resources for the Food and Drug Administration (FDA). The past two years have seen an unprecedented approval of 92 new drugs and 19 new biologics. Information is provided on the 49 new products approved by the FDA in 1997.